𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Gemcitabine and vinorelbine in patients with advanced lung cancer: preclinical studies and report of a phase I trial

✍ Scribed by Roy S. Herbst; Cathleen Lynch; Michael Vasconcelles; Beverly A. Teicher; Gary Strauss; Anthony Elias; Ian Anderson; Patrick Zacarola; Nam H. Dang; Traci Leong; Ravi Salgia; Arthur T. Skarin


Publisher
Springer
Year
2001
Tongue
English
Weight
129 KB
Volume
48
Category
Article
ISSN
0344-5704

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Phase I trial of docetaxel and vinorelbi
✍ Vincent A. Miller; Kenneth K. Ng; Lee M. Krug; Wendy Perez; Barbara Pizzo; Rober πŸ“‚ Article πŸ“… 2000 πŸ› John Wiley and Sons 🌐 English βš– 76 KB πŸ‘ 2 views

## Background: With preclinical evidence of synergy, this dose-finding trial examining the combination of docetaxel and vinorelbine given with prophylactic filgrastim for the treatment of patients with nonsmall cell lung carcinoma was undertaken. ## Methods: Twenty-seven patients with advanced no

Gemcitabine and vinorelbine in advanced
✍ Rogerio Lilenbaum; Roberto Cano; Michael Schwartz; Leonard Siegel; Jose Lutzky; πŸ“‚ Article πŸ“… 2000 πŸ› John Wiley and Sons 🌐 English βš– 73 KB πŸ‘ 2 views

The authors conducted a Phase II study to evaluate the activity of the combination of gemcitabine and vinorelbine in patients with advanced nonsmall cell lung carcinoma (NSCLC). ## METHODS. Patients were eligible if they had Stage IIIB (malignant pleural effusion) or Stage IV NSCLC, no prior chemo